Original Source(s)
Related Content
ASE Plenary: Progress, Priorities, and What’s Next
Efforts to align, sustain, and engage drove a year of growth for ASE.
June 26, 2026
-
4 min
FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI
The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.
June 15, 2026
-
3 min